Community health worker-led integrated care for hypertension and diabetes in Namobuddha
Official title: Community Health Workers Led Integrated Management of Hypertension and Diabetes in Nepal
Run by Kathmandu University School of Medical Sciences · NCT07432126 · Data updated 2026-11-12
This project tests if trained community health workers can improve blood pressure and blood sugar care for adults with hypertension and diabetes in Namobuddha Municipality, Nepal.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 30 Years and up |
| Sex | All |
| Enrollment | 398 (estimated) |
| Sponsor | Kathmandu University School of Medical Sciences Academic / other |
| Locations | 1 site (Kavre, Bagmati) |
| Status | Recruiting |
| Started | December 14, 2025 |
| Main results expected | November 2027 |
| Study ends | November 2027 |
| Registry record updated | March 10, 2026 |
| Trial ID | NCT07432126 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 30 or older with hypertension (BP ≥140/90 mmHg or on antihypertensive medication) and/or diabetes (HbA1c ≥6.5% or on diabetes medication) who can provide informed consent are eligible.
✕Probably not a fit
People with disabilities that limit participation, those with severe illness requiring bed rest, pregnant women, or individuals not served by the municipal health network are unlikely to benefit from this community-based program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a Type II hybrid effectiveness–implementation cluster randomized trial conducted in 12 basic health facilities across Namobuddha Municipality using the RE-AIM framework. Clusters are randomized to an intervention where female community health volunteers (FCHVs) and frontline health workers add diabetes screening, lifestyle counseling, group care, and referral support to existing hypertension activities, versus a control arm receiving standard facility-based care per Ministry of Health guidelines. The trial leverages an existing cohort of about 520 patients enrolled in FCHV-led hypertension programs to follow clinical and implementation outcomes. Investigators will measure reach, adoption, fidelity, and patient-level changes in blood pressure and HbA1c to judge feasibility and effectiveness.
Why it matters
Potential benefit: If successful, this approach could improve blood pressure and blood sugar control, increase diabetes detection, and reduce cardiovascular complications in marginalized communities.
How similar studies have gone: Community health worker-led programs in low-resource settings have improved blood pressure and diabetes outcomes in prior trials, but integrated hypertension–diabetes delivery models in Nepal remain relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 30 years or older * have a high blood pressure of 140/90 mmHg or under hypertension medication * have a high blood sugar of 6.5% or more (hba1c) or under diabetes medication are able to provide informed consent Exclusion Criteria: * any form of disabilities limiting participation in the study * severe illness requiring bed rest, and * pregnant women, due to their special health needs.
Where it's running
-
Institute for Implementation Science and Health
Kavre, Bagmati, Nepal Recruiting
Study contacts
- Principal investigator: Archana Shrestha, PhD — Kathmandu University School of Medical Sciences
- Study coordinator: Archana Shrestha, PhD
- Email: archana@kusms.edu.np
- Phone: 9801002245
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Guiding Optimal Blood Pressure in Peritoneal Dialysis
This pilot tests whether aiming for a lower systolic blood pressure target (<120 mmHg) is feasible and practical for adults with end-stage kidney disease on peritoneal dialysis, compared to a <140 mmHg target.
-
Continuous temperature monitoring of the feet with connected insoles and a smartphone app in adults with diabetes at high risk
This trial tests whether the Solsius SelfCare system can reliably flag pre-ulcer foot changes in adults with diabetes by detecting temperature differences between feet for at least two consecutive days.
-
RIGHTEST iFree 2 CGM system for better diabetes control in adults on insulin
A real-time CGM system is tested to see if it improves blood sugar control for adults with type 1 or type 2 diabetes on insulin, compared with finger-stick monitoring.
-
New virtual care pathway for older adults with chronic diseases
A teleconsultation-based care pathway for adults 60+ with hypertension, diabetes, or dyslipidemia to see if it’s feasible and cost-saving in Malaysian primary care compared with usual clinic visits.
-
Benefits of Retained Insulin for Good Health in Diabetes
This study tests whether preserving or restoring a person’s own insulin production can improve quality of life and blood sugar control for people who need insulin to manage diabetes.
-
Predictive CGM with App for people with type 1 or insulin-treated type 2 diabetes
This study tests whether using the Accu-Chek SmartGuide CGM with its Predict App can reduce fear of hypoglycemia and improve related behaviors and confidence in adults with type 1 or insulin-treated type 2 diabetes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.